Medical device industry executive with 30+ years expertise brings wealth of experience in product development and commercial launches to support Carthera’s future growth
Paris, France, September 18, 2023 – Carthera, a spin-off from Sorbonne University founded by Pr. Alexandre Carpentier and developer of SonoCloud®, an innovative ultrasound-based medical device to treat a wide range of brain disorders, today announces the appointment of Dr. Oern Stuge as chairman of its board of directors.
With the recent closing of its Series B financing round, Carthera is in a strong position to launch an ambitious phase III trial and pursue the evaluation of its SonoCloud technology in multiple clinical indications. In the next few years, the company is aiming at a first market approval for its SonoCloud-9 device for the treatment of recurrent glioblastoma and will prepare accordingly for commercial launch. In this context, Carthera has appointed Dr. Oern Stuge as chairman of its board of directors.